
AIOS is a pioneering company on a mission to revolutionise healthcare through artificial intelligence. As the world’s fastest-growing AI doctor service, AIOS operates at the intersection of cutting-edge technology and patient care.
With a reported annual revenue of $350 million, AIOS has seen remarkable growth powered by its innovative approach to GLP-1 treatments. The company embraces a culture of ambition and perseverance, with a vision to achieve $1 trillion in global healthcare services by 2035.